Find out about these financial services companies by requesting their FREE brochures.
As we approach June, the question on everyone’s lips will be whether the Fed will pull the trigger, some six months after their December hike which brought about a sharp downturn in financial markets in the first half of 2016. Last week’s FOMC minutes sparked a sharp appreciation in the US dollar, which has since led the index to an almost two month high.
With rate hike expectations on the rise, the June meeting is certainly back on the table as a potential action from the Fed. Janet Yellen has reiterated time and time again that each monetary policy decision is ‘data dependent’ in its own right.
Graham Spooner, investment research analyst, picks three stocks from last week’s most-bought shares on the London Stock Exchange.
Investment insights highlights this week are: National Grid, Royal Dutch Shell and Lonmin, which all stand out in a good and in a bad way last week.
Each day, governments, central banks and research firms release important economic statistics and reports that help traders evaluate the economy and financial markets.
The financial calendar helps traders anticipate those releases and take positions accordingly.
On Thursday, 23 June 2016, Britons will be going out to vote en masse in the Brexit referendum. At stake is the UK’s membership of the European Union.
Proponents of a Brexit cite many reasons for their position, including exorbitant fees paid to Brussels every year, security concerns, open borders, stress factors on UK culture, healthcare, coffers and so forth. On the other side of the equation are those who are against a Brexit, including the Prime Minister David Cameron, ranking Tory and Labour members and others.
There are many ways to trade and possibly profit in the capital markets. In deploying a trading strategy investors usually undertake some form of analysis to develop a theme in order to execute a successful trade.
Although the types of analysis used can vary, in general seasoned investors follow some form of fundamental analysis, technical analysis or statistical analysis.
Thu, 1st Jan - * (ShareCast News) - AstraZeneca, the UK's second-biggest drug developer, will this week outline its next big hope in the battle against cancer by unveiling new data on a class of treatments, known as DNA damage response (DDR) medicines, at a conference in Chicago. The drugs work by stopping cancerous cells repairing themselves, in effect by blocking them from attracting the proteins needed to regenerate, as well as proving much less damaging to the body than chemotherapy.